Search

everythinglearnresearchcommunity

for

Search:↓

Some early breast cancer patients have long-term hair loss after chemotherapy, especially older and postmenopausal women.

Topical vitamin D3 does not prevent hair loss from chemotherapy.

Eribulin-based chemotherapy is more effective and has fewer side effects for advanced triple-negative breast cancer.

Vijaya successfully fought stage 2A breast cancer with surgery, chemotherapy, radiotherapy, and hormone therapy, while advocating for support groups.

Scalp cooling is largely ineffective in preventing hair loss from breast cancer chemotherapy.

Adalimumab helped control a child's severe eye disease when other treatments failed.

Most pediatric cancer patients at Muhimbili National Hospital in Tanzania experienced side effects from chemotherapy, with nausea, hair loss, and low white blood cell count being the most common.

A botanical extract was found to be a safe treatment that may prevent hair loss in chemotherapy patients.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

Chemotherapy-induced hair loss is a major concern, but various treatments show promise in preventing and reversing it.

Certain cancer drugs are strongly linked to nerve damage, requiring close monitoring and early treatment.

Chemotherapy caused nail grooves and separation, but they healed after treatment stopped.

A botanical extract may help manage hair loss from chemotherapy by preventing cell death in hair follicles.

Targeting TCR-Vβ2 in cutaneous T cell lymphoma shows promise for safer, more specific treatment.

Bortezomib chemotherapy can cause temporary skin rashes.

Mitoxantrone is effective for treating acute leukemia, especially in older patients, with a lower risk of heart damage.

Chemotherapy can cause significant but usually reversible hair loss, and managing it involves patient education and hair care strategies.

Treatments for acute leukaemia lead to high remission rates, but relapses occur, requiring ongoing advancements in care.

A new topical treatment may prevent hair loss from cancer therapy by adjusting cell death processes in hair follicles.

Chemotherapy is crucial for treating gynecological cancers but requires careful management due to severe side effects.

Early detection of chemotherapy side effects allows treatment adjustments, improving patient outcomes.

Biobran MGN-3 reduces chemotherapy side effects and improves quality of life for breast cancer patients.

Vitamin E in the diet might help protect against hair loss caused by the chemotherapy drug doxorubicin in rabbits.

TICE salvage chemotherapy is effective for treating germ-cell tumors with poor prognosis.

Proper skin toxicity management in chemotherapy is key to continuing treatment and keeping patient quality of life high.

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

Vismodegib effectively treats advanced basal cell carcinoma but requires careful management of serious side effects.

Paclitaxel and nab-paclitaxel can be safe and effective for advanced gastric cancer patients on hemodialysis.

Trastuzumab deruxtecan is effective for HER2-positive breast cancer but requires careful management of side effects.

A man developed alopecia areata after starting cancer treatment with vandetanib.